Research on the Quality of Cancer Care in Diverse Populations

John J. Graff, PhD, MS

John J. Graff, PhD, MS is an associate professor of Radiation Oncology at the Cancer Institute of New Jersey and Robert Wood Johnson Medical School. He is the Division Chief of Cancer Bioinformatics and Surveillance and the Director the New Jersey State Cancer Registry. His research interests include cancer registry-based investigations to identify factors amenable to cancer control and optimize outcomes for patients after a diagnosis of cancer. Dr. Graff’s current work as a co-investigator in CanSORT includes work in outcomes associated with treatment, treatment decisions and patient-provider communication in breast cancer.

Selected Key Papers

  1. Graff JJ, Sathiakumar N, Macaluso M, Maldonado G, Matthews R, Delzell E. The effect of uncertainty in exposure estimation on the exposure-response relation between 1,3-butadiene and leukemia. INT J ENVIRON RES PUBLIC HEALTH. 2009;6(9):2436-2455. PMID: 19826555
  2. Morrow M, Jagsi R, Alderman AK, Griggs JJ, Hawley ST, Hamilton AS, Graff JJ, Katz SJ. Surgeon recommendation and receipt of mastectomy for breast cancer. JAMA, 2009;302(14):1551-1556. PMID: 19826024
  3. Katz, SJ, Hawley ST, Abrahamse P, Morrow M, Friese CR, Alderman AK, Griggs JJ, Hamilton AS, Graff JJ, Hofer TP. Does it matter where you go for breast surgery? Attending surgeon’s influence on variation in receipt of mastectomy for breast cancer. MEDICAL CARE 2010;48(10):1-8. PMID: 20808256
  4. Jagsi R, Abrahamse P, Morrow M, Hawley ST, Griggs JJ, Graff JJ, Hamilton AS, Katz SJ. Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. J CLINICAL ONCOLOGY 2010;28(14):2396-2403. PMID: 20351324
  5. Selected Projects

    1. Surveillance, Epidemiology and End Results (SEER) Program – New Jersey State Cancer Registry (N01PC-2010-00027; Graff (PI); 08/01/10 - 07/31/17) The NCI SEER Program supports the New Jersey State Cancer Registry (NJSCR), a population-based cancer registry, collecting medical and demographic information for all cancer diagnoses for the 8.5 million residents of the State of New Jersey. Information is obtained from all area hospitals, local physicians’ offices, radiation therapy facilities and other facilities, such as hospices.
    2. Disparity in Quality of Breast Cancer Treatment and Effects on Outcomes (R01CA119202; Griggs (PI); 06/01/08-05/31/12) In this research study we are investigating the relationship between the quality of breast cancer adjuvant treatment and disease-free and overall survival; determining whether racial, socioeconomic, and weight-based disparities existing the quality of breast cancer adjuvant treatment and timing of treatments; and verifying that disparities in outcomes exist.
    3. Racial/Ethnic Disparities in Work and Quality of Life Outcomes in Survivors of Breast Cancer (2R01CA109696-04; Hawley (PI); 10/01/08-09/30/11) In this study we are performing a self-administered follow-up survey three years after diagnosis of breast cancer patients to examine racial/ethnic differences in 1) disruption in paid work outcomes within their survivorship period, and 2) quality of life during the survivorship period.
    4. Racial, Ethnic and SES Disparities in Quality of Breast Cancer Systemic Therapy (R01CA139014; Griggs (PI); 12/01/09-11/30/13) In this research study we are examining 1) patterns and correlates of quality of adjuvant chemotherapy and hormone therapy in a diverse population-based sample of women with breast cancer; and 2) variation in the discordance in key pathologic tests between original laboratories and a central laboratory.

    << Back